JPH0639472B2 - Azole derivative - Google Patents
Azole derivativeInfo
- Publication number
- JPH0639472B2 JPH0639472B2 JP3356056A JP35605691A JPH0639472B2 JP H0639472 B2 JPH0639472 B2 JP H0639472B2 JP 3356056 A JP3356056 A JP 3356056A JP 35605691 A JP35605691 A JP 35605691A JP H0639472 B2 JPH0639472 B2 JP H0639472B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- azetidinone
- chemical
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
【0001】本発明は新規なアゾール誘導体に関し、さ
らに詳しくは下記式The present invention relates to a novel azole derivative, more specifically the following formula
【0002】[0002]
【化2】 [Chemical 2]
【0003】式中、 AはCH又はNを表わし、 R1は水素原子又は容易に離脱しうるアミノ保護基を表
わし、 R2及びR3は同一もしくは相異なり、各々水素原子、
低級アルキル基、 フエニル基、ベンジル基又はジフエニルメチル基を表わ
すか、或いは R2とR3は一緒になって低級アルキレン基を表わし、 R 4 は水素原子又は低級アルキル基を表わす、 で示される化合物に関する。In the formula, A represents C H or N, R 1 represents a hydrogen atom or an amino protecting group which can be easily split off, R 2 and R 3 are the same or different and each is a hydrogen atom,
Lower alkyl group, phenyl group, or a benzyl group or Jifuenirumechiru group, or R 2 and R 3 represents a lower alkylene group together, R 4 represents a water atom or a lower alkyl group, in the compounds represented Regarding
【0004】上記式(V)の化合物は、下記式The compound of the above formula (V) has the following formula
【0005】[0005]
【化3】 [Chemical 3]
【0006】式中、Yはアセチル基、1ーヒドロキシエ
チル基又は1ーフルオロエチル基を表わし、R1は水素
原子又は容易に離脱しうるアミノ保護基を表わし、R2
及びR3は同一もしくは相異なり各々水素原子、低級ア
ルキル基、フエニル基、ベンジル基又はジフエニルメチ
ル基を表わすか、或いはR2とR3は一緒になって低級ア
ルキレン基を表わす、で示される化合物の合成中間体と
して有用である。In the formula, Y represents an acetyl group, a 1-hydroxyethyl group or a 1-fluoroethyl group, R 1 represents a hydrogen atom or an easily protecting amino protecting group, and R 2
And R 3 are the same or different and each represents a hydrogen atom, a lower alkyl group, a phenyl group, a benzyl group or a diphenylmethyl group, or R 2 and R 3 together represent a lower alkylene group. It is useful as a synthetic intermediate.
【0007】3−置換アゼチジノン誘導体、殊に4−位
がS−立体配置の3−置換アゼチジノン誘導体は、カル
バペネム系、ペネム系等各種のβ−ラクタム系抗菌性化
合物の製造のための中間体として有用であり、従来各種
のものが提案されている。A 3-substituted azetidinone derivative, particularly a 3-substituted azetidinone derivative having an S-configuration at the 4-position, is used as an intermediate for the production of various β-lactam antibacterial compounds such as carbapenems and penems. It is useful and various types have been proposed.
【0008】今回、本発明者らは、比較的安価なD−マ
ンニトールを出発原料とし、それから誘導されるD−グ
リセルアルデヒドのケタール化物を或る種のアゾール化
合物の存在下にジケテンと反応させると、前記式(I)で
示される4−位がS−立体配置の3−置換−アゼチジノ
ン誘導体が立体選択的に得られることを見い出し、本発
明を完成した。The present inventors now use D-mannitol, which is relatively inexpensive, as a starting material, and react a ketalized product of D-glyceraldehyde derived therefrom with diketene in the presence of a certain azole compound. Then, the inventors have found that a 3-substituted-azetidinone derivative having the S-configuration at the 4-position represented by the above formula (I) can be stereoselectively obtained, and completed the present invention.
【0009】本発明により提案される前記式(I)の化合
物は、各種の医薬品、特にカルバペナム又はカルバペネ
ム系抗生物質、例えば、優れた抗菌活性を有し且つ比較
的安定なカルバペネム系抗生物質として既に知られてい
る下記式The compounds of formula (I) proposed by the present invention have already been used as various drugs, especially carbapenam or carbapenem antibiotics, such as carbapenem antibiotics having excellent antibacterial activity and being relatively stable. Known formula
【0010】[0010]
【化4】 [Chemical 4]
【0011】で示される抗生物質の合成中間体として有
用である。It is useful as an intermediate for the synthesis of antibiotics represented by
【0012】本明細書において「低級」なる語は、この語
が付された基又は化合物の炭素原子数が8個以下、好ま
しくは6個以下であることを意味する。The term "lower" in the present specification means that the group or compound to which this term is attached has 8 or less carbon atoms, preferably 6 or less carbon atoms.
【0013】また、「容易に離脱しうるアミノ保護基」と
しては、該アミノ保護基が結合している化合物の他の部
分に実質的に悪影響を及ぼすことなく、加水分解、還
元、酸化等によって該化合物から除去しうるものが包含
され、例えば、トリメチルシリル、tert−ブチルジメチ
ルシリルなどのトリ(低級アルキル)シリル基;ベンジ
ル、メトキシベンジル、ジメトキシベンジルなどの1個
もしくは2個の低級アルコキシ基で置換されていてもよ
いベンジル基;メトキシフエニル、ジメトキシフエニル
などの1個もしくは2個の低級アルコキシ基で置換され
ていてもよいフエニル基等が挙げられる。Further, the "easily leaving amino protecting group" means that it can be hydrolyzed, reduced, oxidized or the like without substantially adversely affecting other parts of the compound to which the amino protecting group is bonded. Those which can be removed from the compound are included, for example, tri (lower alkyl) silyl group such as trimethylsilyl, tert-butyldimethylsilyl, etc .; substituted with one or two lower alkoxy groups such as benzyl, methoxybenzyl, dimethoxybenzyl, etc. A benzyl group which may be substituted; a phenyl group which may be substituted with one or two lower alkoxy groups such as methoxyphenyl and dimethoxyphenyl, and the like.
【0014】さらに、「低級アルキル基」は直鎖状もしく
は分岐鎖状のいずれのタイプのものであってもよく、例
えば、メチル、エチル、n−プロピル、イソプロピル、n
−ブチル、sec−ブチル、イソブチル、tert−ブチル基
等が挙げられ、「低級アルキレン基」としてはテトラメチ
レン、ペンタメチレンなど炭素数4〜5個のものが好適
である。Further, the "lower alkyl group" may be of a straight chain type or a branched chain type, for example, methyl, ethyl, n-propyl, isopropyl, n.
-Butyl, sec-butyl, isobutyl, tert-butyl groups and the like can be mentioned, and as the "lower alkylene group", those having 4 to 5 carbon atoms such as tetramethylene and pentamethylene are preferable.
【0015】前記式(I)において、Yによって表わされ
うる1−ヒドロキシエチル及び1−フルオロエチル基に
おけるヒドロキシル基及びフツ素原子はS−及びR−の
いずれの立体配置もとりうるが、一般にはフツ素原子は
R−立体配置をとることが望ましい。In the above formula (I), the hydroxyl group and fluorine atom in the 1-hydroxyethyl and 1-fluoroethyl groups which can be represented by Y can have either S- or R-configuration, but in general, The fluorine atom preferably has the R-configuration.
【0016】しかして、本発明により提供される前記式
(I)の化合物の代表例を示せば次のとおりである。Thus, the above formula provided by the present invention
Typical examples of the compound (I) are as follows.
【0017】(3S,4S)−3−アセチル−4−[(4S)
−2,2−ジメチル−1,3−ジオキソラン−4−イル]
−1−(4−メトキシ)フエニル−2−アゼチジノン、 (3S,4S)−4−[(4S)−2,2−ジメチル−1,3−
ジオキソラン−4−イル]−3−[(1S)−1−ヒドロキ
シエチル]−1−(4−メトキシ)フエニル−2−アゼチ
ジノン、 (3S,4S)−4−[(4S)−2,2−ジメチル−1,3−
ジオキソラン−4−イル]−3−[(1R)−1−ヒドロキ
シエチル]−1−(4−メトキシ)フエニル−2−アゼチ
ジノン、 (3R,4S)−4−[(4S)−2,2−ジメチル−1,3−
ジオキソラン−4−イル]−3−[(1R)−1−フルオロ
エチル]−1−(4−メトキシ)フエニル−2−アゼチジ
ノン、 (3S,4S)−3−アセチル−1−ベンジル−4−[(4
S)−2,2−ジメチル−1,3−ジオキソラン−4−イ
ル]−2−アゼチジノン、 (3S,4S)−1−ベンジル−4−[(4S)−2,2−ジ
メチル−1,3−ジオキソラン−4−イル]−3−[(1
S)−1−ヒドロキシエチル]−2−アゼチジノン、 (3S,4S)−1−ベンジル−4−[(4S)−2,2−ジ
メチル−1,3−ジオキソラン−4−イル]−3−[(1
R)−1−ヒドロキシエチル]−2−アゼチジノン、 (3R,4S)−1−ベンジル−4−[(4S)−2,2−ジ
メチル−1,3−ジオキソラン−4−イル]−3−[(1
R)−1−フルオロエチル]−2−アゼチジノン、 (3S,4S)−3−アセチル−1−(2,4−ジメトキシ)
フエニル−4−[(4S)−2,2−ジメチル−1,3−ジ
オキソラン−4−イル]−2−アゼチジノン、 (3S,4S)−1−(2,4−ジメトキシ)フエニル−4−
[(4S)−1,3−ジオキソラン−4−イル]−3−[(1
S)−1−ヒドロキシエチル]−2−アゼチジノン、 (3S,4S)−1−(2,4−ジメトキシ)フエニル−3−
[(1R)−1−ヒドロキシエチル]−4−[(4S)−2−
フエニル−1,3−ジオキソラン−4−イル]−2−アゼ
チジノン、 (3R,4S)−1−(2,4−ジメトキシ)フエニル−4−
{(2S)−1,4−ジオキソスピロ[4,5]デカ−2−イ
ル}−3−[(1R)−1−フルオロエチル]−2−アゼチ
ジノン、 (3S,4S)−3−アセチル−1−(4−メトオキシ)ベ
ンジル−4−[(4S)−2,2−ジメチル−1,3−ジオ
キソラン−4−イル]−2−アゼチジノン、 (3S,4S)−3−[(1S)−1−ヒドロキシエチル]−
1−(4−メトキシ)ベンジル−4−[(4S)−2−フエ
ニル−1,3−ジオキソラン−4−イル]−2−アゼチジ
ノン、 (3S,4S)−4−[(4S)−1,3−ジオキソラン−4
−イル]−3−[(1R)−1−ヒドロキシエチル]−1−
(4−メトキシ)ベンジル−2−アゼチジノン、 (3R,4S)−4−[(4S)−2−エチル−2−メチル−
1,3−ジオキソラン−4−イル]−3−[(1R)−1−
フルオロエチル]−1−(4−メトキシ)ベンジル−2−
アゼチジノン、 (3S,4S)−3−アセチル−4−[(4S)−2,2−ジ
メチル−1,3−ジオキソラン−4−イル]−1−トリメ
チルシリル−2−アゼチジノン、 (3S,4S)−1−t−ブチルジメチルシリル−4−[(4
S)−2,2−ジフエニル−1,3−ジオキソラン−4−
イル]−3−[(1S)−1−ヒドロキシエチル]−2−ア
ゼチジノン、 (3S,4S)−4−[(4S)−2,2−ジメチル−1,3−
ジオキソラン−4−イル]−3−[(1R)−1−ヒドロキ
シエチル]−1−トリメチルシリル−2−アゼチジノ
ン、 (3R,4S)−1−t−ブチルジメチルシリル−3−[(1
R)−1−フルオロエチル]−4−[(4S)−2−メチル
−1,3−ジオキソラン−4−イル]−2−アゼチジノ
ン、 (3S,4S)−3−アセチル−1−(2,4−ジメトキシ)
ベンジル−4−[(4S)−2−フエニル−1,3−ジオキ
ソラン−4−イル]−2−アゼチジノン、 (3S,4S)−3−アセチル−4−[(4S)−2,2−ジ
フエニル−1,3−ジオキソラン−4−イル]−1−(4
−メトキシ)フエニル−2−アゼチジノン、 (3S,4S)−3−アセチル−4−[(4S)−1,3−ジ
オキソラン−4−イル]−1−(4−メトキシ)フエニル
−2−アゼチジノン。(3S, 4S) -3-Acetyl-4-[(4S)
-2,2-Dimethyl-1,3-dioxolan-4-yl]
-1- (4-methoxy) phenyl-2-azetidinone, (3S, 4S) -4-[(4S) -2,2-dimethyl-1,3-
Dioxolan-4-yl] -3-[(1S) -1-hydroxyethyl] -1- (4-methoxy) phenyl-2-azetidinone, (3S, 4S) -4-[(4S) -2,2- Dimethyl-1,3-
Dioxolan-4-yl] -3-[(1R) -1-hydroxyethyl] -1- (4-methoxy) phenyl-2-azetidinone, (3R, 4S) -4-[(4S) -2,2- Dimethyl-1,3-
Dioxolan-4-yl] -3-[(1R) -1-fluoroethyl] -1- (4-methoxy) phenyl-2-azetidinone, (3S, 4S) -3-acetyl-1-benzyl-4- [ (4
S) -2,2-Dimethyl-1,3-dioxolan-4-yl] -2-azetidinone, (3S, 4S) -1-benzyl-4-[(4S) -2,2-dimethyl-1,3 -Dioxolan-4-yl] -3-[(1
S) -1-hydroxyethyl] -2-azetidinone, (3S, 4S) -1-benzyl-4-[(4S) -2,2-dimethyl-1,3-dioxolan-4-yl] -3- [ (1
R) -1-hydroxyethyl] -2-azetidinone, (3R, 4S) -1-benzyl-4-[(4S) -2,2-dimethyl-1,3-dioxolan-4-yl] -3- [ (1
R) -1-Fluoroethyl] -2-azetidinone, (3S, 4S) -3-acetyl-1- (2,4-dimethoxy)
Phenyl-4-[(4S) -2,2-dimethyl-1,3-dioxolan-4-yl] -2-azetidinone, (3S, 4S) -1- (2,4-dimethoxy) phenyl-4-
[(4S) -1,3-dioxolan-4-yl] -3-[(1
S) -1-Hydroxyethyl] -2-azetidinone, (3S, 4S) -1- (2,4-dimethoxy) phenyl-3-
[(1R) -1-hydroxyethyl] -4-[(4S) -2-
Phenyl-1,3-dioxolan-4-yl] -2-azetidinone, (3R, 4S) -1- (2,4-dimethoxy) phenyl-4-
{(2S) -1,4-Dioxospiro [4,5] deca-2-yl} -3-[(1R) -1-fluoroethyl] -2-azetidinone, (3S, 4S) -3-acetyl-1 -(4-methoxy) benzyl-4-[(4S) -2,2-dimethyl-1,3-dioxolan-4-yl] -2-azetidinone, (3S, 4S) -3-[(1S) -1 -Hydroxyethyl]-
1- (4-methoxy) benzyl-4-[(4S) -2-phenyl-1,3-dioxolan-4-yl] -2-azetidinone, (3S, 4S) -4-[(4S) -1, 3-dioxolane-4
-Yl] -3-[(1R) -1-hydroxyethyl] -1-
(4-methoxy) benzyl-2-azetidinone, (3R, 4S) -4-[(4S) -2-ethyl-2-methyl-
1,3-Dioxolan-4-yl] -3-[(1R) -1-
Fluoroethyl] -1- (4-methoxy) benzyl-2-
Azetidinone, (3S, 4S) -3-Acetyl-4-[(4S) -2,2-dimethyl-1,3-dioxolan-4-yl] -1-trimethylsilyl-2-azetidinone, (3S, 4S)- 1-t-butyldimethylsilyl-4-[(4
S) -2,2-Diphenyl-1,3-dioxolane-4-
Iyl] -3-[(1S) -1-hydroxyethyl] -2-azetidinone, (3S, 4S) -4-[(4S) -2,2-dimethyl-1,3-
Dioxolan-4-yl] -3-[(1R) -1-hydroxyethyl] -1-trimethylsilyl-2-azetidinone, (3R, 4S) -1-t-butyldimethylsilyl-3-[(1
R) -1-Fluoroethyl] -4-[(4S) -2-methyl-1,3-dioxolan-4-yl] -2-azetidinone, (3S, 4S) -3-acetyl-1- (2, 4-dimethoxy)
Benzyl-4-[(4S) -2-phenyl-1,3-dioxolan-4-yl] -2-azetidinone, (3S, 4S) -3-Acetyl-4-[(4S) -2,2-diphenyl -1,3-Dioxolan-4-yl] -1- (4
-Methoxy) phenyl-2-azetidinone, (3S, 4S) -3-acetyl-4-[(4S) -1,3-dioxolan-4-yl] -1- (4-methoxy) phenyl-2-azetidinone.
【0018】Yがアセチル基を表わす場合の前記式(I)
の化合物は、例えば下記式The above formula (I) when Y represents an acetyl group
The compound of
【0019】[0019]
【化5】 [Chemical 5]
【0020】式中、R1、R2及びR3は前記の意味を有
する、で示される化合物を、下記式In the formula, R 1 , R 2 and R 3 have the above-mentioned meanings.
【0021】[0021]
【化6】 [Chemical 6]
【0022】式中、 AはCH又はNを表わし、 R 4 は水素原子又は低級アルキル基を表わす、 で示されるアゾール化合物の存在下に、下記式[0022] In the formula, A represents a C H or N, R 4 in the presence of an azole compound represented in represents the water atom or a lower alkyl group, the following formula
【0023】[0023]
【化7】 [Chemical 7]
【0024】で示されるジケテンと反応させることによ
り製造することができる。It can be produced by reacting with a diketene represented by:
【0025】上記式(II)の化合物と式(IV)のジケテンと
の反応は溶媒の不在下又は好ましくは適当な溶媒中、例
えば塩化メチレン、クロロホルム、ジクロロエタン等の
ハロゲン系炭化水素;酢酸エチル、酢酸ブチル等のエス
テル系炭化水素;ジエチルエーテル、テトラヒドロフラ
ン、ジオキサン等のエーテル系炭化水素;ジメチルホル
ムアミド等の中で、一般に約−40℃〜約40℃間、好
ましくは約−20℃〜約25℃間の温度で行なうことが
できる。The reaction of the compound of formula (II) with the diketene of formula (IV) is carried out in the absence of a solvent or preferably in a suitable solvent, for example, a halogenated hydrocarbon such as methylene chloride, chloroform, dichloroethane; ethyl acetate, In ester hydrocarbons such as butyl acetate; ether hydrocarbons such as diethyl ether, tetrahydrofuran, dioxane; etc., generally between about -40 ° C and about 40 ° C, preferably between about -20 ° C and about 25 ° C. It can be performed at temperatures between.
【0026】式(IV)のジケテンに対する式(II)の化合物
の使用割合は厳密に制限されるものではなく、式(II)の
化合物の種類や反応温度等に依存して広範にわたり変え
ることができるが、一般には、式(IV)のジケテン1モル
当り式(II)の化合物を0.5〜3モル、好ましくは0.
8〜1.5モルの割合で用いるのが好都合である。The ratio of the compound of the formula (II) to the diketene of the formula (IV) is not strictly limited and can be varied over a wide range depending on the kind of the compound of the formula (II), the reaction temperature and the like. However, in general, 0.5 to 3 moles of the compound of formula (II) per mole of diketene of formula (IV), preferably 0.1.
It is expedient to use in a proportion of 8 to 1.5 mol.
【0027】また、上記反応において使用される式(II
I)のアゾールとしては、例えば、イミダゾール、2−メ
チルイミダゾール、4−メチルイミダゾール、2,4−
ジメチルイミダゾール、1,2,4−トリアゾール、3−
メチル−1,2,4−トリアゾール、5−メチル−1,2,
4−トリアゾール、3,5−ジメチル−1,2,4−トリ
アゾール等が挙げられ、これらアゾールは式(II)の化合
物1モルに対して一般に0.5〜3モル、好ましくは1
〜1.5モルの割合で使用するのが適当であるが、トリ
アゾール類を用いる場合は、トリエチルアミン、トリブ
チルアミン、ジエチルイソプロピルアミン、1,8−ジ
アザビシクロ[5.4.0]−7−ウンデセン等の有機塩
基を反応補助剤として使用することが必要である。上記
反応によりYがアセチル基を表わす場合の式(I)の化合
物が生成、この化合物は、それ自体既知の方法、例えば
有機溶剤による抽出、結晶化又はシリカゲルカラムクロ
マトグラフイー等の手段により、反応混合物から容易に
単離、精製することができる。In addition, the formula (II
Examples of the azole of I) include imidazole, 2-methylimidazole, 4-methylimidazole, 2,4-
Dimethylimidazole, 1,2,4-triazole, 3-
Methyl-1,2,4-triazole, 5-methyl-1,2,
4-triazole, 3,5-dimethyl-1,2,4-triazole and the like can be mentioned, and these azoles are generally 0.5 to 3 mol, preferably 1 to 1 mol of the compound of the formula (II).
It is suitable to use at a ratio of up to 1.5 moles, but when using triazoles, triethylamine, tributylamine, diethylisopropylamine, 1,8-diazabicyclo [5.4.0] -7-undecene, etc. It is necessary to use the above organic base as a reaction aid. The above reaction produces a compound of formula (I) in which Y represents an acetyl group, which compound is reacted by a method known per se, for example, extraction with an organic solvent, crystallization or silica gel column chromatography. It can be easily isolated and purified from the mixture.
【0028】また、別法として、Yがアセチル基を表わ
す場合の式(I)の化合物は、前記式(II)の化合物と式(II
I)のアゾール化合物との反応により生成する下記式Alternatively, when Y represents an acetyl group, the compound of formula (I) is a compound of formula (II) and a compound of formula (II)
The following formula formed by the reaction of I) with an azole compound
【0029】[0029]
【化8】 [Chemical 8]
【0030】式中、A、R1、R2、R3及びR4は前記の
意味を有する、の化合物を式(IV)のジケテンと反応させ
ることによっても製造することができる。It can also be prepared by reacting a compound of the formula A, R 1 , R 2 , R 3 and R 4 having the abovementioned meaning with a diketene of the formula (IV).
【0031】式(V)の化合物と式(IV)のジケテンとの反
応は、通常前述した如き溶媒中で、一般に約−30℃〜
約40℃、好ましくは約−20℃〜約25℃の温度で行
なうことができる。The reaction of the compound of formula (V) with the diketene of formula (IV) is generally carried out in a solvent as described above, generally at about -30 ° C.
It can be carried out at a temperature of about 40 ° C, preferably about -20 ° C to about 25 ° C.
【0032】式(IV)のジケテンに対する式(V)の化合物
の使用割合は厳密ではなく、式(V)の化合物の種類や反
応温度等に応じて変えうるが、一般には式(IV)のジケテ
ン1モルに対して式(V)の化合物0.5〜2モル、特に
0.8〜1モルの割合で使用するのが好ましい。The proportion of the compound of the formula (V) used with respect to the diketene of the formula (IV) is not critical and may be varied depending on the type of the compound of the formula (V), the reaction temperature, etc. The compound of the formula (V) is preferably used in an amount of 0.5 to 2 mol, particularly 0.8 to 1 mol, per 1 mol of diketene.
【0033】かくして生成するYがアセチル基を表わす
場合の式(I)の化合物は前記と同様の手段で反応混合物
から単離、精製することができる。The compound of formula (I) in which Y thus formed represents an acetyl group can be isolated and purified from the reaction mixture by the same means as described above.
【0034】以上述べた反応において出発原料として使
用される式(II)の化合物はそれ自体既知のものであり、
例えば下記式The compounds of formula (II) used as starting materials in the reactions mentioned above are known per se,
For example, the following formula
【0035】[0035]
【化9】 [Chemical 9]
【0036】式中、R2及びR3は前記の意味を有する、
で示される1・2,5・6−O−ジケタール化D−マン
ニトールを酸化分解して(例えば過ヨウ素酸又は四酢酸
鉛を用いて)下記式Wherein R 2 and R 3 have the meanings given above,
The oxidative decomposition of 1,2,5,6-O-diketalized D-mannitol represented by the following formula (for example, using periodic acid or lead tetraacetate)
【0037】[0037]
【化10】 [Chemical 10]
【0038】式中、R2及びR3は前記の意味を有する、
で示されるD−グリセルアルデヒドのケタール化物を下
記式Wherein R 2 and R 3 have the meanings given above,
The ketalized product of D-glyceraldehyde represented by
【0039】[0039]
【化11】R1−NH2 (VIII) 式中、R1は前記の意味を有する、で示されるアミンと
反応させシツフ塩基とすることにより容易に製造するこ
とができる。Embedded image R 1 —NH 2 (VIII) In the formula, R 1 has the above-mentioned meaning, and can be easily produced by reacting with an amine represented by
【0040】一方、式(V)の化合物は従来の文献に未載
の新規な化合物であり、例えば、式(II)の化合物と式(I
V)のジケテンとの反応について述べた如き溶媒中で、式
(II)の化合物を式(III)のアゾール化合物と反応させる
ことにより製造することができる。その際の反応温度は
一般に約−40℃〜約40℃、好ましくは約−20℃〜
約25℃間の温度が適当である。また、式(II)の化合物
に対する式(III)の化合物の使用割合は厳密に制限され
るものではないが、一般には式(II)の化合物1モルに対
して式(III)の化合物0.5〜2モル、好ましくは1〜
1.5モルの割合で使用するのが好都合である。 生成
する式(V)の化合物は一旦反応混合物から単離した後、
式(III)のジケテンと反応させてもよいが、単離するこ
となくそのまま式(III)のジケテンと反応させてもよ
い。On the other hand, the compound of the formula (V) is a novel compound which has not been described in the conventional literatures.
V) in a solvent as described for the reaction of diketene with the formula
It can be produced by reacting a compound of (II) with an azole compound of formula (III). In that case, the reaction temperature is generally about -40 ° C to about 40 ° C, preferably about -20 ° C.
Temperatures between about 25 ° C are suitable. Further, the ratio of the compound of the formula (III) to the compound of the formula (II) is not strictly limited, but in general, 1 mol of the compound of the formula (II) is added to the compound of the formula (III). 5 to 2 mol, preferably 1 to
Conveniently, it is used in a proportion of 1.5 mol. The resulting compound of formula (V) once isolated from the reaction mixture,
It may be reacted with the diketene of the formula (III), or may be directly reacted with the diketene of the formula (III) without isolation.
【0041】前述の如くして製造されるYがアセチル基
を表わす場合の式(I)の化合物は、還元することにより
該アセチル基を1−ヒドロキシメチル基に変えることが
できる。Yがアセチル基を表わす場合の式(I)の化合物
の還元は、通常ジエチルエーテル、テトラヒドロフラ
ン、ジメトキシエタン等のエーテル系炭化水素;エタノ
ール、メタノール等のアルコール系炭化水素;ベンゼ
ン、トルエン等の芳香族系炭化水素等の溶媒中におい
て、例えば水素化ホウ素ナトリウム、水素化ホウ素リチ
ウム、水素化アルミニユウムリチウム、マグネシウムト
リフロロアセテート−ジイソプロピルアミンーボラン、
水素化トリ−sec−ブチルホウ素、リチウム(L−セレク
トライド)、水素化トリ−sec−ブチルホウ素カリウム、
水素化ジイソブチルアルミニユウム(DIBAL)等の還
元剤を用いて行なうことができる。この還元剤の選択に
より、例えば水素化ホウ素リチウム、L−セレクトライ
ドを用いた場合には1S−ヒドロキシエチル基が得ら
れ、また例えば水素化ジイソブチルアルミニユウム (DIBAL)、マグネシウムトリフロロアセテート−ジ
イソプロピルアミン−ボランを用いた場合には1R−ヒ
ドロキシエチル基が得られる。The compound of formula (I) in which Y represents an acetyl group produced as described above can be converted to the 1-hydroxymethyl group by reducing the acetyl group. When Y represents an acetyl group, the reduction of the compound of formula (I) is generally carried out by ether hydrocarbons such as diethyl ether, tetrahydrofuran and dimethoxyethane; alcohol hydrocarbons such as ethanol and methanol; aromatic hydrocarbons such as benzene and toluene. In a solvent such as a system hydrocarbon, for example, sodium borohydride, lithium borohydride, lithium aluminum hydride, magnesium trifluoroacetate-diisopropylamine-borane,
Tri-sec-butylboron hydride, lithium (L-selectride), potassium tri-sec-butylboron hydride,
It can be carried out using a reducing agent such as diisobutylaluminium hydride (DIBAL). By selecting this reducing agent, for example, lithium borohydride, 1S-hydroxyethyl group is obtained when L-selectride is used, and also diisobutylaluminium hydride (DIBAL), magnesium trifluoroacetate-diisopropylamine is obtained. -When borane is used, a 1R-hydroxyethyl group is obtained.
【0042】上記還元反応は用いる還元剤の種類にもよ
るが一般には−78℃〜40℃、好ましくは−78℃〜
25℃の温度で実施することができる。また、還元剤の
使用量は臨界的ではないが、一般には、Yがアセチル基
を表わす場合の式(I)の化合物1モルに対して0.5〜
10モル、好ましくは1〜4モルの割合で使用するのが
好適である。The above-mentioned reduction reaction depends on the type of reducing agent used, but is generally -78 ° C to 40 ° C, preferably -78 ° C to
It can be carried out at a temperature of 25 ° C. Although the amount of the reducing agent used is not critical, it is generally 0.5 to 1 mol of the compound of the formula (I) when Y represents an acetyl group.
It is suitable to use it in a proportion of 10 mol, preferably 1 to 4 mol.
【0043】かくして得られるYが1−ヒドロキシエチ
ル基を表わす式(I)の化合物は次いでフツ素化すること
により、Yが1−フルオロエチル基を表わす場合の対応
する式(I)の化合物が得られる。Yが1−ヒドロキシエ
チル基を表わす式(I)の化合物のフツ素化は、それ自体
既知の方法に従い、例えばジエチルアミノサルフアート
リフルオライド(DAST)を用い、チングポングマツク
ら、ヘテロサイクルス(Heterocycles)19,1399
(1982)に記載の方法又は石川試薬(ヘキサフルオロ
プロペン−ジエチルアミン混合試薬)で行なうことがで
き、これにより、1−ヒドロキシエチル基におけるS−
立体配置のOHはR−立体配置のFに立体選択的に置換
されて、Yが1R−フルオロエチル基を表わす場合の対
応する式(I)の化合物が得られる。The thus obtained compound of formula (I) in which Y represents a 1-hydroxyethyl group is then fluorinated to give the corresponding compound of formula (I) in which Y represents a 1-fluoroethyl group. can get. The fluorination of the compound of formula (I) in which Y represents a 1-hydroxyethyl group is carried out according to a method known per se, for example, using diethylaminosulfate trifluoride (DAST), Chingpongmatsuk et al., Heterocycles. ) 19 , 1399
(1982) or the Ishikawa reagent (hexafluoropropene-diethylamine mixed reagent), whereby S- at the 1-hydroxyethyl group can be obtained.
The OH of the configuration is stereoselectively substituted with the F of the R-configuration to give the corresponding compound of formula (I) when Y represents a 1R-fluoroethyl group.
【0044】かくして得られる下記式The following formula thus obtained
【0045】[0045]
【化12】 [Chemical 12]
【0046】式中、R1、R2及びR3は前記の意味を有
する、で示される化合物は、例えば下記反応式Aに従
い、前記式(A)の抗生物質に誘導することができる。In the formula, R 1 , R 2 and R 3 have the above-mentioned meanings, and the compounds represented by the following formula A can be converted into the antibiotic of formula (A).
【0047】[0047]
【化13】 [Chemical 13]
【0048】[0048]
【化14】 [Chemical 14]
【0049】[0049]
【化15】 [Chemical 15]
【0050】上記反応式中、R11は容易に離脱しうるア
ミノ保護基を表わす。In the above reaction formula, R 11 represents an amino protecting group which can be easily removed.
【0051】R1が容易に離脱しうるアミノ保護基を表
わす場合の式(I−1)の化合物の加水分解は、それ自体
既知の方法に従い、該化合物を例えば酢酸−水混合溶液
と共に約25℃〜約60℃で処理することにより行なう
ことができる。The hydrolysis of the compound of formula (I-1) in which R 1 represents an easily leaving amino protecting group is carried out according to a method known per se, for example by mixing the compound with an acetic acid-water mixed solution at about 25. It can be carried out by treating at a temperature of from 60 to 60 ° C.
【0052】生成する式(1)の化合物の酸化は、通常
ベンゼン、トルエン、テトラビトロフラン、テトラヒド
ロフラン−水、ジメトキシエタン−水、含水メタノー
ル、含水エタノール等の溶媒中で、例えば過ヨウ素酸、
メタ過ヨウ素酸ナトリウム、四酢酸鉛、等の酸化剤を用
いて行なうことができる。また、上記酸化反応は一般に
約−10℃〜約50℃間、好ましくは約0℃〜約25℃
間の温度で実施することができる。Oxidation of the resulting compound of formula (1) is usually carried out in a solvent such as benzene, toluene, tetravitrofuran, tetrahydrofuran-water, dimethoxyethane-water, water-containing methanol, water-containing ethanol or the like, for example, periodic acid,
It can be carried out using an oxidizing agent such as sodium metaperiodate or lead tetraacetate. In addition, the above-mentioned oxidation reaction is generally between about -10 ° C and about 50 ° C, preferably about 0 ° C to about 25 ° C.
It can be carried out at temperatures between.
【0053】酸化剤の使用量は厳密に制限されるもので
はなく、用いる酸化剤の種類等に応じて変えうるが、一
般には式(1)の化合物1モルに対して酸化剤0.5〜
5モル、好ましくは1〜1.5モルの割合で用いるのが
好適である。The amount of the oxidant used is not strictly limited and may be varied depending on the kind of the oxidant used and the like, but generally 0.5 to 1 mol of the compound of the formula (1) is used.
It is preferably used in a proportion of 5 mol, preferably 1 to 1.5 mol.
【0054】これにより式(2)の化合物が得られ、こ
の化合物は次いでジヨーンズ酸化又はKMnO4−t−Bu
OH−5%NaH2PO4の試薬を用いる酸化に付すこと
により式(3)の化合物に変えることができる。上記ジ
ヨーンズ酸化又は上記試薬を用いる酸化それ自体既知の
方法、例えばデイ・ジエイ・ハート(D.J.Hart)
ら、テトラヘドロン・レターズ(Tetrahedron Letter
s)26,5493(1985)及びアツシ・アビコ(Atsus
hi Abiko)ら、テトラヘドロン・レターズ(Tetrahedr
on Letters)27,4537(1980)に記載の方法に
従って行なうことができる。This gives the compound of the formula (2) which is then subjected to the diones oxidation or KMnO 4 -t-Bu.
It can be converted into compounds of formula (3) by subjecting to oxidation with a reagent of OH-5% NaH 2 PO 4 . The above-mentioned Djones oxidation or the oxidation using the above-mentioned reagent is a method known per se, for example, DJ Hart.
Tetrahedron Letters
s) 26 , 5493 (1985) and Atsushi Abiko (Atsus)
hi Abiko) et al., Tetrahedron Letters (Tetrahedr
on Letters) 27 , 4537 (1980).
【0055】かくして得られる式(3)の化合物は次い
で四酢酸鉛を用いて酸化的に脱炭酸を行なうことによ
り、式(4)の化合物とすることができる。この酸化的
脱炭酸もそれ自体既知の方法、例えばピー・ジエイ・リ
ーダー(P.J.Reider)ら、テトラヘドロン・レター
ズ(Tetrahedron Letters)23,2293(1982)
に記載の方法に準じて行なうことができる。生成する式
(4)の化合物の1−位のアミノ保護基は、そのアミノ
保護基の種類に応じた適当な脱アミノ保護基反応[例え
ばR11がトリ(低級アルキル)シリル基の場合は酸加水分
解、R11が未置換もしくは置換ベンジル基の場合は水素
化分解、そしてR11がp−メトキシフエニル又はo,p−ジ
メトキシフエニル基の場合は酸化適脱離]により離脱さ
せ、式(5)の化合物に導くこともできる。なお、トリ
メチルシリル基の場合は脱保護することなく次の反応に
供してもよい。The compound of formula (3) thus obtained can then be converted to the compound of formula (4) by oxidatively decarboxylation using lead tetraacetate. This oxidative decarboxylation is also a method known per se, for example, PJ Reider et al., Tetrahedron Letters 23 , 2293 (1982).
It can be performed according to the method described in. The 1-position amino-protecting group of the compound of formula (4) to be produced is subjected to a suitable deamination-protecting group reaction depending on the kind of the amino-protecting group [for example, an acid when R 11 is a tri (lower alkyl) silyl group]. By hydrolysis, when R 11 is an unsubstituted or substituted benzyl group, hydrogenolysis, and when R 11 is a p-methoxyphenyl or o, p-dimethoxyphenyl group, suitable elimination by oxidation] It is also possible to lead to the compound of (5). In the case of a trimethylsilyl group, it may be used in the next reaction without deprotection.
【0056】式(5)の化合物から式(A)の化合物に至
る工程は、下記の試薬を用い、下記の文献に記載の方法
に従つて製造することができる。The steps from the compound of formula (5) to the compound of formula (A) can be produced using the following reagents and according to the methods described in the following documents.
【0057】試 薬 [0057] Reagents
【0058】[0058]
【化16】 [Chemical 16]
【0059】文 献 1) ダブリユ・フリツチ(W.Flitsch)ら、テトラヘド
ロン・レターズ(Tetrahedron Letters)23, 229
7(1982) 2) デイ・ジー・メリロ(D.G.Melillo)ら、テトラ
ヘドロン・レターズ(Tetrahedron Letters)21, 2
783(1980) 上記の如くして製造される式(A)の抗生物質は広範囲か
つ優れた抗菌活性を有し、しかも腎デヒドロペプチダー
ゼに対しても安定であり、抗菌剤として極めて有用であ
る。 Document 1) W. Flitsch et al., Tetrahedron Letters 23 , 229
7 (1982) 2) DG Melillo et al., Tetrahedron Letters 21 , 2
783 (1980) The antibiotic of formula (A) produced as described above has a wide range and excellent antibacterial activity and is stable against renal dehydropeptidase, and is extremely useful as an antibacterial agent.
【0060】次に実施例により本発明を更に具体的に説
明する。Next, the present invention will be described more specifically by way of examples.
【0061】参考例N−(4−メトキシ)フエニル−{[(4S)−2,2−ジメ
チル−1,3−ジオキソラン−4−イル]メタン}イミン
の製造 Reference Example N- (4-methoxy) phenyl-{[(4S) -2,2-dimer
Tyl-1,3-dioxolan-4-yl] methane} imine
Manufacturing of
【0062】[0062]
【化17】 [Chemical 17]
【0063】1,2,5,6−O−ジイソプロビリデン−
D−マンニトール5g(19mmol)を、メタノール24ml
に溶解し、氷冷下、5%炭酸水素ナトリウム水溶液、
7.75mlを加え、メタ過ヨウ素酸5.865gと、水3
2.8mlを合わせて、加えた。同温度で、1時間撹拌し
た。反応液中の不溶物を濾去し、濾液を、塩化メチレン
で3回抽出し、合わせた抽出液を飽和食塩水で、洗浄し
た後、無水硫酸ナトリウムで乾燥した。乾燥後、無水硫
酸ナトリウムを濾去し、濾液を濃縮すると、1,2−O
−イソプロピリデン−D−グリセルアルデヒドが得られ
た。この時、溶媒留去は、温度をかけず、塩化メチレン
のみを留去せしめた。次いで、収量の0.8当量のアニ
シジンを秤取ベンジンに溶かし、窒素雰囲気下、1,2
−O−イソプロピリデン−D−グリセルアルデヒドのベ
ンゼン溶液に加え、さらに無水硫酸ナトリウムを適量加
えて、一昼夜撹拌した。反応後、無水硫酸ナトリウムを
濾去し、濾液を濃縮すると、表題化合物が7.2g、80
%の収率で得られた。1,2,5,6-O-diisopropylidene-
D-mannitol 5 g (19 mmol) was added to methanol 24 ml.
Dissolved in 5% sodium hydrogencarbonate aqueous solution under ice cooling,
Add 7.75 ml, metaperiodic acid 5.865 g and water 3
2.8 ml were combined and added. The mixture was stirred at the same temperature for 1 hour. The insoluble matter in the reaction solution was filtered off, the filtrate was extracted three times with methylene chloride, the combined extracts were washed with saturated brine and then dried over anhydrous sodium sulfate. After drying, anhydrous sodium sulfate was filtered off and the filtrate was concentrated to give 1,2-O.
-Isopropylidene-D-glyceraldehyde was obtained. At this time, the solvent was distilled off without heating, and only methylene chloride was distilled off. Then, the yield of 0.8 equivalents of anisidine was dissolved in weighed benzine, and the solution was stirred under nitrogen atmosphere for 1,2.
To the benzene solution of -O-isopropylidene-D-glyceraldehyde was added an appropriate amount of anhydrous sodium sulfate, and the mixture was stirred overnight. After the reaction, anhydrous sodium sulfate was filtered off, and the filtrate was concentrated to give the title compound (7.2 g, 80 g).
% Yield.
【0064】1H−NMR(CDCl3) 1 H-NMR (CDCl 3 )
【0065】[0065]
【化18】 [Chemical 18]
【0066】 [0066]
【0067】[0067]
【実施例】 実施例11−{[(4S)−2,2−ジメチル−1,3−ジオキソラン
−4−イル]−(4−メトキシ)フエニルイミノ}メチルイ
ミダゾールの製造 EXAMPLES Example 1 1-{[(4S) -2,2-dimethyl-1,3-dioxolane
-4-yl]-(4-methoxy) phenylimino} methylyl
Manufacture of midazole
【0068】[0068]
【化19】 [Chemical 19]
【0069】N−(4−メトキシ)フエニル−{[(4S)
−2,2−ジメチル−1,3−ジオキソラン−4−イル]
メタン}イミン30mg(0.13mmol)を無水塩化メチレン
1mlに溶解し、イミダゾール8.7mg(0.13mmol,1e
q.)を室温で加え、同温にて窒素雰囲気下5分間反応
後、濃縮乾固して、1−{[(4S)−2,2−ジメチル−
1,3−ジオキソラン−4−イル]−(4−メトキシ)フエ
ニルイミノ}メチルイミダゾールが定量的に得られた。N- (4-methoxy) phenyl-{[(4S)
-2,2-Dimethyl-1,3-dioxolan-4-yl]
30 mg (0.13 mmol) of methane} imine was dissolved in 1 ml of anhydrous methylene chloride, and 8.7 mg of imidazole (0.13 mmol, 1e)
q. ) Was added at room temperature, reacted at the same temperature for 5 minutes under a nitrogen atmosphere, concentrated to dryness, and 1-{[(4S) -2,2-dimethyl-
1,3-Dioxolan-4-yl]-(4-methoxy) phenylimino} methylimidazole was obtained quantitatively.
【0070】1H−NMR(CDCl3) δ(ppm)=1.45,1.47,1.53,1.60(6
H,m 1 H-NMR (CDCl 3 ) δ (ppm) = 1.45, 1.47, 1.53, 1.60 (6
H, m
【0071】[0071]
【化20】 [Chemical 20]
【0072】 6.40〜6.95(4H,m,Ar−H),7.03(2H,m,H
−4&H−5),7.60,7.68(1H,s,H−2) 実施例21−{[(4S)−2,2−ジメチル−1,3−ジオキソラン
−4−イル]−(4−メトキシ)フエニルイミノ}メチル−
1,2,4−トリアゾールの製造 [0072] 6.40-6.95 (4H, m, Ar- H ), 7.03 (2H, m, H
-4 & H-5), 7.60, 7.68 (1H, s, H-2) Example 2 1-{[(4S) -2,2-dimethyl-1,3-dioxolane
-4-yl]-(4-methoxy) phenylimino} methyl-
Production of 1,2,4-triazole
【0073】[0073]
【化21】 [Chemical 21]
【0074】N−(4−メトキシ)フエニル−{[(4S)
−2,2−ジメチル−1,3−ジオキソラン−4−イル]
メタン}イミン30mg(0.13mmol)を無水塩化メチレン
1mlに溶解し、1,2,4−トリアゾール8.97mg(0.
13mmol)を室温で加え、同温にて窒素雰囲気下10分
間反応後、濃縮乾固して、1−{[(4S)−2,2−ジメ
チル−1,3−ジオキソラン−4−イル]−(4−メトキ
シ)フエニルイミノ}メチル−1,2,4−トリアゾールが
定量的に得られた。N- (4-methoxy) phenyl-{[(4S)
-2,2-Dimethyl-1,3-dioxolan-4-yl]
30 mg (0.13 mmol) of methane} imine was dissolved in 1 ml of anhydrous methylene chloride, and 8.97 mg (0.1%) of 1,2,4-triazole was dissolved.
13 mmol) at room temperature and reacted at the same temperature for 10 minutes under a nitrogen atmosphere and then concentrated to dryness to give 1-{[(4S) -2,2-dimethyl-1,3-dioxolan-4-yl]-. (4-Methoxy) phenylimino} methyl-1,2,4-triazole was obtained quantitatively.
【0075】1H−NMR(CDCl3) 1 H-NMR (CDCl 3 )
【0076】[0076]
【化22】 [Chemical formula 22]
【0077】4.22〜4.90(3H,m,H−4′,H−
5′a,H−5′b),4.22 to 4.90 (3H, m, H-4 ', H-
5'a, H-5'b),
【0078】[0078]
【化23】 [Chemical formula 23]
【0079】6.66〜7.05(4H,m,Ar−H),8.1
0−(1H,s,H−3),8.25,8.30(1H,s,H−5) 実施例3(3S,4S)−3−アセチル−4−[(4S)−2,2−ジ
メチル−1,3−ジオキソラン−4−イル]−1−(4−
メトキシ)フエニル−2−アゼチジノンの製造 6.66 to 7.05 (4H, m, Ar- H ), 8.1
0- (1H, s, H-3), 8.25,8.30 (1H, s, H-5) Example 3 (3S, 4S) -3-Acetyl-4-[(4S) -2,2-di
Methyl-1,3-dioxolan-4-yl] -1- (4-
Production of (methoxy) phenyl-2-azetidinone
【0080】[0080]
【化24】 [Chemical formula 24]
【0081】実施例1によつて得られた1−{[(4S)−
2,2−ジメチル−1,3−ジオキソラン−4−イル]−
(4−メトキシ)フエニルイミノ}メチルイミダゾール6.
45g(21.3mmol)を無水塩化メチレン40mlに溶解
し、−20℃、窒素雰囲気下ジケテン2.45ml(31.
95mmol)を加えた。同温にて30分撹拌した後、室温
にもどして150分間撹拌した後、氷を入れた塩化メチ
レンと0.5N塩酸の混液に反応液をあけ、洗浄し、再
度0.5N塩酸で洗浄した後(合計:0.5N塩酸65ml×
2回)、飽和食塩水で洗浄し、芒硝にて乾燥した。芒硝
を濾去し、シリカゲルカラムクロマトグラフイーで精製
して(トルエン→トルエン/酢酸エチル=50/1→3
0/1→20/1→15/1)、4.60gの表題の化合
物が収率67.6%で得られた。1-{[(4S) -obtained according to Example 1
2,2-Dimethyl-1,3-dioxolan-4-yl]-
(4-Methoxy) phenylimino} methylimidazole 6.
45 g (21.3 mmol) was dissolved in 40 ml of anhydrous methylene chloride, and 2.45 ml (31.
95 mmol) was added. After stirring at the same temperature for 30 minutes, returning to room temperature and stirring for 150 minutes, the reaction solution was poured into a mixed solution of methylene chloride and 0.5N hydrochloric acid containing ice, washed, and washed again with 0.5N hydrochloric acid. After (total: 0.5 ml hydrochloric acid 65 ml x
(Twice), washed with a saturated saline solution, and dried with Glauber's salt. Glauber's salt was removed by filtration and purified by silica gel column chromatography (toluene → toluene / ethyl acetate = 50/1 → 3
(0/1 → 20/1 → 15/1), 4.60 g of the title compound was obtained with a yield of 67.6%.
【0082】1H−NMR(CDCl3) 1 H-NMR (CDCl 3 )
【0083】[0083]
【化25】 [Chemical 25]
【0084】[0084]
【化26】 [Chemical formula 26]
【0085】 H−5′a),3.70(3H,s,OCH3),4.05
(1H,dd,J=6.5Hz,J=9.0Hz,H−5′b),4.
12(1H,d,J=2.5Hz,H−3),4.4〜4.6(2
H,m,H−4′,H−4),6.75(2H,d,J=9.
0Hz,H−3”,H−5”),7.22(2H,d,
J=9.0Hz,H−2”,H−6”) [α]D 22.5=−87.3°(c=1,CHCl3) 実施例4(3S,4S)-3-アセチル-4-[(4S)-2,2-ジメチル-
1,3-ジオキソラン-4-イル]-1-(4-メトキシ)フエニ
ル‐2‐アゼチジノンの製造 [0085] H-5'a), 3.70 (3H , s, OCH 3), 4.05
(1H, dd, J = 6.5Hz, J = 9.0Hz, H-5'b), 4.
12 (1H, d, J = 2.5Hz, H-3), 4.4 to 4.6 (2
H, m, H-4 ', H-4), 6.75 (2H, d, J = 9.
0Hz, H-3 ", H-5"), 7.22 (2H, d,
J = 9.0Hz, H-2 ", H-6") [Α] D 22.5 = -87.3 ° (c = 1, CHCl 3 ) Example 4 (3S, 4S) -3-Acetyl-4-[(4S) -2,2-dimethyl-
1,3-Dioxolan-4-yl] -1- (4-methoxy) phenyl
Production of le-2-azetidinone
【0086】[0086]
【化27】 [Chemical 27]
【0087】実施例2によつて得られた1‐{[(4S)‐
2,2‐ジメチル‐1,3‐ジオキソラン‐4‐イル]‐
(4‐メトキシ)フエニルイミノ}メチル‐1,2,4‐ト
リアゾール30mg(0.1mmol)を無水塩化メチレンに溶
解し、−20℃、窒素雰囲気下、13.9μl(0.1mmo
l、1eq.)のトリエチルアミンを加え、11.5μl(0.
15mmol、1.5eq.)のジケテンを加えて室温で3時間
撹拌した後、氷を加えた塩化メチレンと0.5N塩酸の
混液に反応液をあけ、抽出洗浄し、0.5N塩酸で再洗
し、飽和食塩水で洗浄した後、芒硝乾燥し、シリカゲル
カラムクロマトグラフイー(前記参照)にて精製して、
3.1mgの表題の化合物が収率10%で得られ、このも
のの理化学的性状は、実施例3で得られた化合物のそれ
に一致した。1-{[(4S) -obtained according to Example 2
2,2-Dimethyl-1,3-dioxolan-4-yl]-
30 mg (0.1 mmol) of (4-methoxy) phenylimino} methyl-1,2,4-triazole was dissolved in anhydrous methylene chloride, and 13.9 μl (0.1 mmo) at −20 ° C. under nitrogen atmosphere.
l, 1 eq.) of triethylamine was added, and 11.5 μl (0.
(15 mmol, 1.5 eq.) Was added, and the mixture was stirred at room temperature for 3 hours. The reaction solution was poured into a mixture of methylene chloride and 0.5N hydrochloric acid with ice, extracted, washed, and washed again with 0.5N hydrochloric acid. , Washed with saturated saline, dried with sodium sulfate, purified by silica gel column chromatography (see above),
3.1 mg of the title compound was obtained with a yield of 10%, the physicochemical properties of which were in agreement with those of the compound obtained in Example 3.
【0088】実施例5(3S,4S)-3-[(1S)-1-ヒドロキシエチル]-4-
[(4S)-2,2-ジメチル-1,3-ジオキソラン-4-イル]
-1-(4-メトキシ)フエニル‐2‐アゼチジノンの製造 Example 5(3S, 4S) -3-[(1S) -1-Hydroxyethyl] -4-
[(4S) -2,2-Dimethyl-1,3-dioxolan-4-yl]
Preparation of -1- (4-methoxy) phenyl-2-azetidinone
【0089】[0089]
【化28】 [Chemical 28]
【0090】(3S,4S)-3-アセチル-4-[(4S)-2,
2-ジメチル-1,3-ジオキソラン-4-イル]-1-(4-メ
トキシ)フエニル‐2‐アゼチジノン300mg(0.94m
mol)を5.5mlの無水テトラヒドロフランに溶解し、−
70℃窒素雰囲気下1.13ml(1.13mmol、1.2eq.)
のL-セレクトライドを滴下し、同温にて1時間撹拌し
た後0.135ml(2.37mmol、2.1eq.)の酢酸を加え
た。5分間撹拌した後、30mlの酢酸エチルで抽出し、
飽和食塩水10mlで2回、次に飽和炭酸水素ナトリウム
水溶液15mlで1回、再び飽和食塩水10mlでそれぞれ
洗浄した後、芒硝で乾燥した。芒硝を濾去し、シリカゲ
ルカラムクロマトグラフイーで精製して(トルエン→ト
ルエン/酢酸エチル=5/1→3/1→2/1)、表題
の化合物が264.0mg、収率87.5%で得られた。な
お、該化合物の異性体である3位の(1R)-1-ヒドロキ
シエチル体は得られなかつた。1 H−NMR(CDCl3) δ(ppm)=1.29〜1.38(9H、m、(3S, 4S) -3-Acetyl-4-[(4S) -2,
2-Dimethyl-1,3-dioxolan-4-yl] -1- (4-methoxy) phenyl-2-azetidinone 300 mg (0.94 m
(mol) was dissolved in 5.5 ml of anhydrous tetrahydrofuran,
1.13 ml (1.13 mmol, 1.2 eq.) Under nitrogen atmosphere at 70 ° C
L-Selectride of was added dropwise and stirred at the same temperature for 1 hour, and then 0.135 ml (2.37 mmol, 2.1 eq.) Of acetic acid was added. After stirring for 5 minutes, extract with 30 ml of ethyl acetate,
The extract was washed twice with 10 ml of saturated saline solution, once with 15 ml of saturated aqueous sodium hydrogen carbonate solution and once again with 10 ml of saturated saline solution, and dried with sodium sulfate. Glauber's salt was removed by filtration and purified by silica gel column chromatography (toluene → toluene / ethyl acetate = 5/1 → 3/1 → 2/1) to obtain 264.0 mg of the title compound, yield 87.5%. Obtained in. The (1R) -1-hydroxyethyl compound at the 3-position, which is an isomer of the compound, was not obtained. 1 H-NMR (CDCl 3 ) δ (ppm) = 1.29 to 1.38 (9 H, m,
【0091】[0091]
【化29】 [Chemical 29]
【0092】CH−CH3 )、2.49(1H、d、J=3.
6Hz、OH)、3.19(1H、dd、J=2.1Hz、J=
5.1Hz、H−3)、3.72(3H、s、OCH3)、3.
62〜 (1H、dt、J=3.5Hz、J=7.5Hz、H−
4′)、6.79(2H、d、J=9.5Hz、H−3”及び
H−5”)、7.28(2H、d、J=9.5Hz、H−2”
及びH−6”) [α]D 23=−60.7°(c=1、CHCl3)。[0092] CH-C H 3), 2.49 (1H, d, J = 3.
6Hz, OH), 3.19 (1H, dd, J = 2.1Hz, J =
5.1Hz, H-3), 3.72 (3H, s, OCH 3), 3.
62 ~ (1H, dt, J = 3.5Hz, J = 7.5Hz, H-
4 '), 6.79 (2H, d, J = 9.5Hz, H-3 "and H-5"), 7.28 (2H, d, J = 9.5Hz, H-2 "
And H-6 ") [α] D 23 = -60.7 ° (c = 1, CHCl 3).
【0093】実施例6(3S,4S)-3-[(1R)および(1S)-1-ヒドロキシ]
エチル-4-[(4S)-2,2-ジメチル-1,3-ジオキソラ
ン-4-イル]-1-(4-メトキシ)フエニル‐2‐アゼチジ
ノンの製造 Example 6 (3S, 4S) -3-[(1R) and (1S) -1-hydroxy]
Ethyl-4-[(4S) -2,2-dimethyl-1,3-dioxola
N-4-yl] -1- (4-methoxy) phenyl-2-azetidi
Non production
【0094】[0094]
【化30】 [Chemical 30]
【0095】(3S,4S)-3-アセチル-4-[(4S)-2,
2-ジメチル-1,3-ジオキソラン-4-イル]-1-(4-メ
トキシ)フエニル‐2‐アゼチジノン50.3mg(0.16
mmol)を無水テトラヒドロフラン1.6mlに溶解し、ジイ
ソブチルアルミニウムハイドレート(DIBAL)240
μl(0.24mmol、1.5eq.)を窒素雰囲気下に−70
℃にて滴下し、30分以上撹拌した。反応終了後、酢酸
29.3μl(0.51mmol)を同温で加え反応をとめ、2
0mlの酢酸エチルで抽出した。この抽出液を飽和食塩水
で1回洗浄した後、さらに飽和炭酸水素ナトリウム水溶
液で1回洗浄し、飽和食塩水で再び洗浄した後、芒硝乾
燥し、芒硝を濾去して、シリカゲルカラムクロマトグラ
フイーにて精製して(トルエン→トルエン/酢酸エチル
=5/1→3/1→2/1、CH2Cl2でチヤージ)32
mgの(3S,4S)-3-[(1R)および(1S)-1-ヒドロキ
シ]エチル-4-[(4S)-2,2-ジメチル-1,3-ジオキソ
ラン−4−イル]-1‐(4-メトキシ)フエニル‐2‐ア
ゼチジノン混合物が収率64%で得られた。この混合物
中の(1R)体と(1S)体の比は約3:1であつた。(3S, 4S) -3-Acetyl-4-[(4S) -2,
2-Dimethyl-1,3-dioxolan-4-yl] -1- (4-methoxy) phenyl-2-azetidinone 50.3 mg (0.16)
mmol) in 1.6 ml of anhydrous tetrahydrofuran, and diisobutylaluminum hydrate (DIBAL) 240
μl (0.24 mmol, 1.5 eq.) under nitrogen atmosphere was -70.
The mixture was added dropwise at 0 ° C and stirred for 30 minutes or longer. After the reaction was completed, 29.3 μl (0.51 mmol) of acetic acid was added at the same temperature to stop the reaction and 2
It was extracted with 0 ml of ethyl acetate. The extract was washed once with a saturated saline solution, further washed once with a saturated sodium hydrogencarbonate aqueous solution, washed again with a saturated saline solution, dried with mirabilite, filtered out to remove mirabilite, and subjected to silica gel column chromatography. Purified by E (toluene → toluene / ethyl acetate = 5/1 → 3/1 → 2/1, CH 2 Cl 2 charge) 32
mg of (3S, 4S) -3-[(1R) and (1S) -1-hydroxy] ethyl-4-[(4S) -2,2-dimethyl-1,3-dioxolan-4-yl] -1 A-(4-methoxy) phenyl-2-azetidinone mixture was obtained with a yield of 64%. The ratio of the (1R) form to the (1S) form in this mixture was about 3: 1.
【0096】1H−NMR(CDCl3) δ(ppm)=1.28〜1.50(9H、m、 1 H-NMR (CDCl 3 ) δ (ppm) = 1.28 to 1.50 (9 H, m,
【0097】[0097]
【化31】 [Chemical 31]
【0098】CH−CH3 )、2.12〜2.40(1H、
m、OH)、3.10(2/3H、dd、J=2.5Hz、J=
6.0Hz、1R体のH−3)、3.18(1/3H、dd、
J=2.5Hz、J=6.0Hz、1S体のH−3)、3.7
0(3H、s、OCH3)、3.71 )、6.79(2H、d、J=9Hz、H−3”、H−
5”)、7.28(2H、d、J=9Hz、H−2”、H−
6”) 実施例7−1(3R,4S)-3-[(1R)-1-フルオロエチル]-4-[(4
S)-2,2-ジメチル-1,3-ジオキソラン-4-イル]-1-
(4-メトキシ)フエニル‐2‐アゼチジノンの製造 [0098] CH-C H 3), 2.12~2.40 (1H,
m, OH), 3.10 (2 / 3H, dd, J = 2.5Hz, J =
6.0 Hz, 1R H-3), 3.18 (1 / 3H, dd,
J = 2.5 Hz, J = 6.0 Hz, 1S body H-3), 3.7
0 (3H, s, OCH 3 ), 3.71 ), 6.79 (2H, d, J = 9Hz, H-3 ", H-
5 "), 7.28 (2H, d, J = 9Hz, H-2", H-
6 ″) Example 7-1 (3R, 4S) -3-[(1R) -1-fluoroethyl] -4-[(4
S) -2,2-Dimethyl-1,3-dioxolan-4-yl] -1-
Preparation of (4-methoxy) phenyl-2-azetidinone
【0099】[0099]
【化32】 [Chemical 32]
【0100】(3S,4S)-3-[(1S)-1‐ヒドロキシ
エチル]‐4‐[(4S)‐2,2-ジメチル-1,3-ジオキ
ソラン-4-イル]-1-(4-メトキシ)フエニル‐2‐アゼ
チジノン87.9mg(0.27mmol)を無水塩化メチレン
1.5mlに溶解し、0℃、窒素雰囲気下、ヘキサフルオ
ロプロペン‐ジエチルアミン混合試薬(石川試薬)60.
8μl(0.18mmol)を滴下した。反応液を15℃にも
どして、40分間撹拌し、反応終了後0℃に冷却したp
H7.4のリン酸緩衝液20mlを加えて5分間撹拌し
た。その後塩化メチレンで抽出し、(20ml1回、10m
l 1回)有機層を、飽和食塩水で洗浄し、芒硝乾燥し
た。芒硝を濾去し、シリカゲルカラムクロマトグラフイ
ーで精製して(トルエン→トルエン/EtOAc=20/
1→15/1→10/1→5/1→3/1)、表題の化
合物が56.1mg収率64.3%で得られた。(3S, 4S) -3-[(1S) -1-Hydroxyethyl] -4-[(4S) -2,2-dimethyl-1,3-dioxolan-4-yl] -1- (4 -Methoxy) phenyl-2-azetidinone (87.9 mg, 0.27 mmol) was dissolved in anhydrous methylene chloride (1.5 ml), and the mixture was mixed with hexafluoropropene-diethylamine (Ishikawa reagent) at 0 ° C under a nitrogen atmosphere.
8 μl (0.18 mmol) was added dropwise. The reaction solution was returned to 15 ° C, stirred for 40 minutes, and cooled to 0 ° C after completion of the reaction.
20 ml of H7.4 phosphate buffer was added and stirred for 5 minutes. After that, extract with methylene chloride (20 ml once, 10 m
The organic layer was washed with saturated saline and dried with sodium sulfate. Glauber's salt was filtered off and purified by silica gel column chromatography (toluene → toluene / EtOAc = 20 /
1 → 15/1 → 10/1 → 5/1 → 3/1), and the title compound was obtained in a yield of 56.1 mg, 64.3%.
【0101】1H−NMR(CDCl3) 1 H-NMR (CDCl 3 )
【0102】[0102]
【化33】 [Chemical 33]
【0103】[0103]
【化34】 [Chemical 34]
【0104】(3H、dd、J=6Hz、J=24Hz、CH
F−CH 3)、3.19(1H、ddd、J=2.4Hz、J=
7.5Hz、J=16.5Hz、H−3)、3.62(3H、
s、OCH3)、3.6〜4.0(3H、m、H−4、H−5
a′、H−5b′)4.31(1H、dt、J=2.4Hz、J=
6.0Hz、H−4′)4.74(1H、ddq、J=46.5
Hz、J=7.5Hz、J=6.0Hz、CHF−CH3)、
6.58(2H、d、J=9Hz、H−3”、H−5”)、
7.03(2H、d、J=9Hz、H−2”、H−6”) [α]D 22.5=−76.4°(c=1、CHCl3)。(3H, dd, J = 6Hz, J = 24Hz, CH
F-C H 3), 3.19 (1H, ddd, J = 2.4Hz, J =
7.5Hz, J = 16.5Hz, H-3), 3.62 (3H,
s, OCH 3), 3.6~4.0 ( 3H, m, H-4, H-5
a ', H-5b') 4.31 (1H, dt, J = 2.4Hz, J =
6.0 Hz, H-4 ') 4.74 (1H, ddq, J = 46.5)
Hz, J = 7.5Hz, J = 6.0Hz, C H F-CH 3),
6.58 (2H, d, J = 9Hz, H-3 ", H-5"),
7.03 (2H, d, J = 9Hz, H-2 ", H-6") [α] D 22.5 = -76.4 ° (c = 1, CHCl 3 ).
【0105】実施例7−2(3R,4S)-3-[(1R)-1-フルオロエチル]-4-[(4
S)-2,2-ジメチル-1,3-ジオキソラン-4-イル]-1-
(4-メトキシ)フエニル‐2‐アゼチジノンの製造(変
法) Example 7-2(3R, 4S) -3-[(1R) -1-fluoroethyl] -4-[(4
S) -2,2-Dimethyl-1,3-dioxolan-4-yl] -1-
Preparation of (4-methoxy) phenyl-2-azetidinone
Law)
【0106】[0106]
【化35】 [Chemical 35]
【0107】(3S,4S)-3-[(1S)‐1‐ヒドロキシ
エチル]‐4-[(4S)-2,2-ジメチル-1,3-ジオキソ
ラン-4-イル]-1-(4-メトキシ)フエニル‐2‐アゼチ
ジノン151.8mg(0.47mmol)を無水塩化メチレン3
mlに溶解し、窒素雰囲気下−50℃にて、ジエチルアミ
ノサルフア‐トリフルオライド(DAST)93.1μl
(0.71mmol、1.5eq.)を滴下した。1時間撹拌後、
氷を入れた飽和炭酸水素ナトリウム水溶液と塩化メチレ
ンの混液に反応液をあけ過剰のDASTを分解した後、
有機層を飽和食塩水で洗浄し、シリカゲルカラムクロマ
トグラフイーにて精製して(トルエン→トルエン/EtO
Ac=20/1→15/1→10/1→5/1→3/
1)、表題の化合物が71.2mg、収率46.9%で得ら
れた。このものの理化学的性状は前記実施例7−1で得
られたものと一致した。(3S, 4S) -3-[(1S) -1-Hydroxyethyl] -4-[(4S) -2,2-dimethyl-1,3-dioxolan-4-yl] -1- (4 -Methoxy) phenyl-2-azetidinone (151.8 mg, 0.47 mmol) in anhydrous methylene chloride (3)
9 ml of diethylaminosulfur-trifluoride (DAST) at a temperature of -50 ° C under nitrogen atmosphere.
(0.71 mmol, 1.5 eq.) Was added dropwise. After stirring for 1 hour,
After the reaction solution was poured into a mixed solution of saturated sodium hydrogen carbonate aqueous solution and methylene chloride containing ice to decompose excess DAST,
The organic layer was washed with saturated brine and purified by silica gel column chromatography (toluene → toluene / EtO).
Ac = 20/1 → 15/1 → 10/1 → 5/1 → 3 /
1), 71.2 mg of the title compound was obtained with a yield of 46.9%. The physicochemical properties of this product were the same as those obtained in Example 7-1.
【0108】実施例8(3R,4S)-4-[(1S)-1,2-ジヒドロキシエチル]-
3-[(1R)-1-フルオロエチル]-1-(4-メトキシ)フエ
ニル‐2‐アゼチジノンの製造 Example 8 (3R, 4S) -4-[(1S) -1,2-dihydroxyethyl]-
3-[(1R) -1-fluoroethyl] -1- (4-methoxy) phenyl
Production of Nyl-2-azetidinone
【0109】[0109]
【化36】 [Chemical 36]
【0110】(3R,4S)-3-[(1R)‐1‐フルオロエ
チル]‐4-[(4S)-2,2-ジメチル-1,3-ジオキソラ
ン-4-イル]-1-(4-メトキシ)フエニル‐2‐アゼチジ
ノン127.3mg(0.39mmol)を酢酸:水=4:1の混液
10.4mlに溶解し、40℃にて14時間反応させた。
反応終了後濃縮し、シリカゲルカラムクロマトグラフイ
ーにて精製して(トルエン→トルエン/EtOAc=2/
1→1/1→1/2→1/3、塩化メチレンでチヤー
ジ)、表題の化合物が104.3mg、収率94.5%で得
られた。(3R, 4S) -3-[(1R) -1-Fluoroethyl] -4-[(4S) -2,2-dimethyl-1,3-dioxolan-4-yl] -1- (4 127.3 mg (0.39 mmol) of -methoxy) phenyl-2-azetidinone was dissolved in 10.4 ml of a mixed solution of acetic acid: water = 4: 1 and reacted at 40 ° C for 14 hours.
After completion of the reaction, the mixture is concentrated and purified by silica gel column chromatography (toluene → toluene / EtOAc = 2 /
(1 → 1/1 → 1/2 → 1/3, charged with methylene chloride) to give the title compound (104.3 mg, yield 94.5%).
【0111】NMR(CDCl3) δ(ppm)=1.42(3H、dd、J=7.2Hz、J=24.
6Hz、CHF−CH 3)、2.85(1H、t、J=6.0
Hz、2′-OH)、3.30(1H、m、H−3)、3.55
(2H、m、H−5′a、H−5′b)、3.70(3H、s、
OCH3)、4.04〜4.15(2H、m、H−4、H−
4′)、4.87(1H、ddq、J=7.2Hz、J=48.
0Hz、J=5.4Hz、CHF−CH3)、6.73(2
H、d、J=9.3Hz、H−3”、H−5”)、7.20
(2H、d、J=9.3Hz、H−2”、H−6”) [α]D 22=−63.4°(c=1.19、CHCl3) 実施例 9(3R,4S)‐3‐[(1R)‐1‐フルオロエチル]‐4
‐ホルミル‐1‐(4‐メトキシ)フエニル‐2‐アゼチ
ジノンの製造 NMR (CDCl 3 ) δ (ppm) = 1.42 (3H, dd, J = 7.2Hz, J = 24.
6Hz, CHF-C H 3) , 2.85 (1H, t, J = 6.0
Hz, 2'-OH), 3.30 (1H, m, H-3), 3.55
(2H, m, H-5'a, H-5'b), 3.70 (3H, s,
OCH 3), 4.04~4.15 (2H, m, H-4, H-
4 '), 4.87 (1H, ddq, J = 7.2Hz, J = 48.
0Hz, J = 5.4Hz, C H F-CH 3), 6.73 (2
H, d, J = 9.3 Hz, H-3 ", H-5"), 7.20
(2H, d, J = 9.3Hz, H-2 ", H-6") [α] D 22 = -63.4 ° (c = 1.19, CHCl 3 ) Example 9 (3R, 4S) -3-[(1R) -1-fluoroethyl] -4
-Formyl-1- (4-methoxy) phenyl-2-azeti
Zinone production
【0112】[0112]
【化37】 [Chemical 37]
【0113】(3R,4S)‐4‐[(1S)‐1,2‐ジヒ
ドロキシエチル]‐3‐[(1R)‐1‐フルオロエチル]
‐1‐(4‐メトキシ)フエニル‐2‐アゼチジノン4
7.5mg(0.17mmol)をテトラヒドロフラン(THF)
0.8mlに溶解し、窒素雰囲気下、過ヨウ素酸48.4mg
(0.21mmol、1.25eq.)を1mlのTHFに溶解して
加える。反応終了後、酢酸エチル30mlで抽出し、飽和
炭酸水素ナトリウム水溶液、飽和亜硫酸ナトリウム水溶
液、さらに飽和食塩水で洗った後、シリカゲルカラムク
ロマトグラフイーにて精製して(トルエン→トルエン/
EtOAC=3/1→2/1→1/1→1/2→1/3 塩化メチレンチ
ヤージ)表題の化合物が26.0mg、収率61.0%で得
られた。(3R, 4S) -4-[(1S) -1,2-dihydroxyethyl] -3-[(1R) -1-fluoroethyl]
-1- (4-methoxy) phenyl-2-azetidinone 4
7.5 mg (0.17 mmol) of tetrahydrofuran (THF)
Dissolve in 0.8 ml and under period of nitrogen, periodic acid 48.4 mg
(0.21 mmol, 1.25 eq.) Dissolved in 1 ml THF is added. After completion of the reaction, the mixture was extracted with 30 ml of ethyl acetate, washed with a saturated aqueous solution of sodium hydrogen carbonate, a saturated aqueous solution of sodium sulfite and saturated saline, and then purified by silica gel column chromatography (toluene → toluene / toluene /
EtOAC = 3/1 → 2/1 → 1/1 → 1/2 → 1/3 methylene chloride) The title compound was obtained in an amount of 26.0 mg in a yield of 61.0%.
【0114】1H−NMR(CDCl3) δ(ppm)=1.49(3H、dd、J=6.0Hz、J=24
Hz、CHF−CH 3)、3.35(1H、ddd、J=2.7
Hz、J=5.7Hz、J=21Hz、H−3)、3.72
(3H、s、OCH3)、4.40(1H、dd、J=2.7H
z、J=3.0Hz、H−4)5.0(1H、ddq、J=46.
2Hz、J=5.7Hz、J=6.0Hz、CHF−C
H3)、6.75(2H、d、J=9Hz、H−3′、H−
5′)、7.12(2H、d、J=9Hz、H−2′、H−
6′)、9.65(1H、d、J=3Hz、CHO) 〔α〕D 22=−118.9°(C=1,CHCl3) 実施例 10(3R、4S)‐4‐カルボキシ‐3‐[(1R)‐1‐フ
ルオロエチル]‐1‐(4‐メトキシ)フエニル‐2‐ア
ゼチジノンの製造 1 H-NMR (CDCl 3 ) δ (ppm) = 1.49 (3H, dd, J = 6.0 Hz, J = 24)
Hz, CHF-C H 3) , 3.35 (1H, ddd, J = 2.7
Hz, J = 5.7 Hz, J = 21 Hz, H-3), 3.72
(3H, s, OCH 3 ), 4.40 (1H, dd, J = 2.7H
z, J = 3.0 Hz, H-4) 5.0 (1H, ddq, J = 46.
2Hz, J = 5.7Hz, J = 6.0Hz, C H F-C
H 3), 6.75 (2H, d, J = 9Hz, H-3 ', H-
5 '), 7.12 (2H, d, J = 9Hz, H-2', H-
6 '), 9.65 (1H, d, J = 3Hz, CHO) [Α] D 22 = -118.9 ° (C = 1, CHCl 3 ). Example 10 (3R, 4S) -4-carboxy-3-[(1R) -1-ph
Luoroethyl] -1- (4-methoxy) phenyl-2-a
Zetidinone production
【0115】[0115]
【化38】 [Chemical 38]
【0116】(3R、4S)‐3‐[(1R)‐1‐フルオ
ロエチル]‐4‐ホルミル‐1‐(4‐メトキシ)フエニ
ル‐2‐アゼチジノン40.6mg(0.16mmol)を1mlの
tert‐ブタノールに溶解し、pH6.7のリン酸緩衝液
0.64mlを加え、1M過マンガン酸カリウム0.96ml
を室温で加えて45分間撹拌した。反応終了後、氷冷下
4mlの飽和亜硫酸ナトリウム水溶液を加え撹拌した後、
1N塩酸でpH2〜3に調整した。25ml酢酸エチルで
2回抽出し、有機層を飽和食塩水で洗浄した。食塩水層
は酢酸エチルで再抽出し、先の有機層とあわせ芒硝で乾
燥後、芒硝で濾去、濃縮して、表題の化合物が45.6m
g、定量的に得られた。(3R, 4S) -3-[(1R) -1-fluoroethyl] -4-formyl-1- (4-methoxy) phenyl-2-azetidinone 40.6 mg (0.16 mmol) in 1 ml
Dissolve in tert-butanol, add 0.64 ml of pH 6.7 phosphate buffer, 0.96 ml of 1M potassium permanganate.
Was added at room temperature and stirred for 45 minutes. After completion of the reaction, 4 ml of saturated aqueous sodium sulfite solution was added under ice cooling and the mixture was stirred.
The pH was adjusted to 2-3 with 1N hydrochloric acid. It was extracted twice with 25 ml of ethyl acetate, and the organic layer was washed with saturated saline. The saline layer was re-extracted with ethyl acetate, combined with the previous organic layer, dried over Glauber's salt, filtered off with Glauber's salt and concentrated to give 45.6 m of the title compound.
g, quantitatively obtained.
【0117】1H−NMR(CDCl3) δ(ppm)=1.32(3H、dd、J=6.3Hz、J=24
Hz、CHF−CH 3)、3.32(1H、ddd、J=3Hz、
J=4.8Hz、J=25.2Hz、H−3)、3.58(3
H、s、OCH3)、4.38(1H、d、J=3Hz、H−
4)、4.95(1H、ddq、J=4.8Hz、J=48H
z、J=6.3Hz、CHF−CH3)、6.73(2H、
d、J=9Hz、H−3′、H−5′)、7.08(2H、
d、J=9Hz、H−2′、H−6′)、8.72(1H、
s、COOH) 〔α〕D 22=−84.6°(c=1.0,CH3OH) 実施例 11(3R,4R)及び(3R,4S)‐4‐アセトキシ‐3‐
〔(R)‐1‐フルオロエチル〕‐1‐(p‐メトキシ)フ
エニル-2-アゼチジノンの製造 [0117]1H-NMR (CDCl3) δ (ppm) = 1.32 (3H, dd, J = 6.3Hz, J = 24)
Hz, CHF-CH 3) 3.32 (1H, ddd, J = 3Hz,
J = 4.8 Hz, J = 25.2 Hz, H-3), 3.58 (3
H, s, OCH3), 4.38 (1H, d, J = 3Hz, H-
4) 4.95 (1H, ddq, J = 4.8Hz, J = 48H
z, J = 6.3Hz, CHF-CH3), 6.73 (2H,
d, J = 9Hz, H-3 ', H-5'), 7.08 (2H,
d, J = 9Hz, H-2 ', H-6'), 8.72 (1H,
s, COOH)[Α]D twenty two= -84.6 ° (c = 1.0, CH3OH) Example 11(3R, 4R) and (3R, 4S) -4-acetoxy-3-
[(R) -1-fluoroethyl] -1- (p-methoxy) phenyl
Production of enyl-2-azetidinone
【0118】[0118]
【化39】 [Chemical Formula 39]
【0119】(3R,4S)-4-カルボキシ-3-〔(R)-1
-フルオロエチル〕-1-(p-メトキシ)フエニル-2-アゼ
チジノン65mg(0.24mmole)、四酢酸鉛216mg(0.
49mmole)、酢酸0.2ml、ジメチルホルムアミド0.6
mlの混合液を65℃、15分間反応させた。反応液を酢
酸エチルに注ぎ飽和食塩水で洗浄後無水硫酸ナトリウム
で乾燥した。溶媒を留去後ベンゼンに溶解し、シリカゲ
ルカラム7gに吸着させ、ベンゼン、ベンゼン/酢酸エ
チル(50/1)、(40/1)、(20/1)で溶出させた。溶出
区分でベンゼン/酢酸エチル(3/1)展開のシリカゲル
TLCにてRf値0.75及び0.57にUV吸収を示す
区分を集めて減圧濃縮すると目的の化合物シス体及びト
ランス体がそれぞれ7mg、43mg得られた(全収率73
%)。これらの化合物はベンゼン‐n‐ヘキサンより結晶
化できた。(3R, 4S) -4-carboxy-3-[(R) -1
-Fluoroethyl] -1- (p-methoxy) phenyl-2-azetidinone 65 mg (0.24 mmole), lead tetraacetate 216 mg (0.2
49mmole), acetic acid 0.2ml, dimethylformamide 0.6
The mixed solution of ml was reacted at 65 ° C. for 15 minutes. The reaction mixture was poured into ethyl acetate, washed with saturated brine and dried over anhydrous sodium sulfate. After the solvent was distilled off, the residue was dissolved in benzene, adsorbed on a silica gel column (7 g) and eluted with benzene, benzene / ethyl acetate (50/1), (40/1) and (20/1). In the elution section, silica gel TLC developed with benzene / ethyl acetate (3/1) was used to collect the sections showing UV absorption at Rf values of 0.75 and 0.57, and concentrated under reduced pressure to obtain 7 mg of the target compound, cis and trans, respectively. , 43 mg were obtained (total yield 73
%). These compounds could be crystallized from benzene-n-hexane.
【0120】シス化合物の理化学的性状 融点 156−160℃ 〔α〕D 22+42.7°(c=0.62,CHCl3) NMR(CDCl3) δ;1.60(3H,dd,J=24.0および6.0Hz,CH3
‐CHF) 2.17(3H,s,OAc) 3.68(1H,m,H−3) 3.70(3H,s,OMe) 5.17(1H,m,CH3−CHF) 6.83(1H,d,J=6.0Hz,H−4)Physicochemical properties of cis compound Melting point 156-160 ° C. [α] D 22 + 42.7 ° (c = 0.62, CHCl 3 ). NMR (CDCl 3 ) δ; 1.60 (3H, dd, J = 24.0 and 6.0Hz, CH 3
-CHF) 2.17 (3H, s, OAc) 3.68 (1H, m, H-3) 3.70 (3H, s, OMe) 5.17 (1H, m, CH 3 -C H F) 6.83 (1H, d, J = 6.0Hz, H-4)
【0121】[0121]
【化40】 [Chemical 40]
【0122】トランス化合物の理化学的性状 融点 121−123.5℃ 〔α〕D 22−51.4°(c=1.013,CHCl3) NMR(CDCl3) δ;1.55(3H,d,J=24.0&6.5Hz、CH3 −C
HF) 2.10(3H,s,OAc) 3.40(1H,ddd,J=1.5&5.0&24.5Hz、H
−3) 3.79(3H,s,OMe) 5.07(1H,ddq,H=48.0&5.0&6.5Hz,CH
3−CHF−) 6.62(1H,d,J=1.5Hz、H−4)[0122] Physicochemical Properties mp 121-123.5 ° C. trans compound [α] D 22 -51.4 ° (c = 1.013 , CHCl 3) NMR (CDCl 3 ) δ; 1.55 (3H, d, J = 24.0 & 6.5Hz, CH 3 -C
HF) 2.10 (3H, s, OAc) 3.40 (1H, ddd, J = 1.5 & 5.0 & 24.5Hz, H
-3) 3.79 (3H, s, OMe) 5.07 (1H, ddq, H = 48.0 & 5.0 & 6.5Hz, CH
3 -C H F-) 6.62 (1H , d, J = 1.5Hz, H-4)
【0123】[0123]
【化41】 [Chemical 41]
【0124】実施例 12(3R,4R)‐4‐アセトキシ‐3‐〔(R)‐1‐フル
オロエチル〕‐2‐アゼチジノンの製造 Example 12 (3R, 4R) -4-acetoxy-3-[(R) -1-fur
Production of Oroethyl] -2-azetidinone
【0125】[0125]
【化42】 [Chemical 42]
【0126】(3R,4R)‐4‐アセトキシ‐3‐
〔(R)‐1-フルオロエチル〕‐1‐(p‐メトキシ)フエ
ニル‐2‐アゼチジノン30mg(0.11mmole)をアセト
ニトリル1.5mlに溶解後氷冷し、セリツクアンモニウ
ムナイトレート175.5mg(0.32mmole)の水溶液1.
5mlを徐々に滴下した。(3R, 4R) -4-acetoxy-3-
30 mg (0.11 mmole) of [(R) -1-fluoroethyl] -1- (p-methoxy) phenyl-2-azetidinone was dissolved in 1.5 ml of acetonitrile and cooled with ice to give 175.5 mg of seric ammonium nitrate ( A solution of 0.32mmole) 1.
5 ml was gradually added dropwise.
【0127】同温度で25分間反応させた後反応液を酢
酸エチル50mlに注ぎ5%炭酸水素ナトリウム水溶液で
洗浄した。洗浄液は再び酢酸エチルで抽出し、有機層を
合わせ10%チオ硫酸ナトリウム水溶液、5%炭酸水素
ナトリウム水溶液、飽和食塩水で各1回洗浄した。After reacting for 25 minutes at the same temperature, the reaction solution was poured into 50 ml of ethyl acetate and washed with a 5% aqueous sodium hydrogen carbonate solution. The washing solution was extracted again with ethyl acetate, and the organic layers were combined and washed once with a 10% sodium thiosulfate aqueous solution, a 5% sodium hydrogen carbonate aqueous solution, and a saturated saline solution.
【0128】有機層は無水硫酸ナトリウムで乾燥後減圧
濃縮すると、表題化合物が15mg得られた(収率81
%)。The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain 15 mg of the title compound (yield 81
%).
【0129】この化合物はベンゼン‐n‐ヘキサンより
結晶化した。This compound was crystallized from benzene-n-hexane.
【0130】融点 98.5−102℃ 〔α〕D 22+116.8°(c=1.0,CHCl3) 1745(エステルCO) NMR(CDCl3) δ;1.50(3H,dd,J=6.5&24.0Hz、CH3 −
CHF) 2.13(3H,s,COCH3) 3.40(1H,ddd,J=1.5&5.5&24.0Hz、H
−3) 5.00(1H,dqiunt,J=48.0&6.5Hz、CH3−
CHF−) 5.90(1H,d,J=1.5Hz、H−4) 6.85(1H,br,NH) 実施例 134‐〔(3R,4R)‐3‐((R)‐1‐フルオロエチル)
‐2‐オキソアゼチジン‐4‐イル〕‐2‐ジアゾ‐3
‐オキソ酪酸p‐ニトロベンジルエステルの製造 Melting point 98.5-102 ° C. [α] D 22 + 116.8 ° (c = 1.0, CHCl 3 ). 1745 (ester CO) NMR (CDCl 3 ) δ; 1.50 (3H, dd, J = 6.5 & 24.0Hz, CH 3 −
CHF) 2.13 (3H, s, COCH 3 ) 3.40 (1H, ddd, J = 1.5 & 5.5 & 24.0Hz, H
-3) 5.00 (1H, dqiunt, J = 48.0 & 6.5Hz, CH 3 −
C H F-) 5.90 (1H, d, J = 1.5Hz, H-4) 6.85 (1H, br, NH) Example 13 4 - [(3R, 4R) -3 - ( (R ) -1-Fluoroethyl)
-2-Oxoazetidin-4-yl] -2-diazo-3
Of 2-oxobutyric acid p-nitrobenzyl ester
【0131】[0131]
【化43】 [Chemical 43]
【0132】(3R,4R)‐4‐アセトキシ‐3‐
〔(R)‐1-フルオロエチル〕‐2‐アゼチジノン 2
0mg(0.11mmole)を塩化メチレン1mlに溶解後氷冷
し、ヨウ化亜鉛36mg(0.11mmole)を加えた。この混
合物に0℃でp‐ニトロベンジル 2‐ジアゾ‐3‐(ト
リメチルシリル)オキシ‐3‐ブテノエート96mg(0.
29mmole)の塩化メチレン溶液(1ml)を13分間かけて
ゆっくり滴下した。(3R, 4R) -4-acetoxy-3-
[(R) -1-fluoroethyl] -2-azetidinone 2
After dissolving 0 mg (0.11 mmole) in 1 ml of methylene chloride and cooling with ice, 36 mg (0.11 mmole) of zinc iodide was added. To this mixture at 0 ° C. was added 96 mg of p-nitrobenzyl 2-diazo-3- (trimethylsilyl) oxy-3-butenoate (0.
A solution of 29 mmole) in methylene chloride (1 ml) was slowly added dropwise over 13 minutes.
【0133】反応液は0℃で20分間ついで室温で2時
間撹拌した。反応液を酢酸エチルで希釈し、5%炭酸水
素ナトリウム水溶液、水、飽和食塩水で順次洗浄し、無
水硫酸ナトリウムにて乾燥した。The reaction solution was stirred at 0 ° C. for 20 minutes and then at room temperature for 2 hours. The reaction mixture was diluted with ethyl acetate, washed successively with 5% aqueous sodium hydrogen carbonate solution, water and saturated brine, and dried over anhydrous sodium sulfate.
【0134】溶媒を留去して得られた残渣を少量の塩化
メチレンを用いてシリカゲル6gに吸着させ、ベンゼン
/アセトン(10/1)(8/1)(5/1)の順に展開した。
溶出部のうちベンゼン/アセトン(3/1)を展開系とす
るTLC上、Rf0.36にUV吸収を有する区分を集め
て減圧乾固すると、表題化合物が27mg(収率62%)得
られた。The residue obtained by distilling off the solvent was adsorbed on 6 g of silica gel using a small amount of methylene chloride and developed in the order of benzene / acetone (10/1) (8/1) (5/1).
When the fractions having UV absorption at Rf 0.36 were collected on TLC using benzene / acetone (3/1) as a developing system in the eluate and dried under reduced pressure, 27 mg (yield 62%) of the title compound was obtained. .
【0135】この化合物の理化学的性状 融点 90−92℃ 〔α〕D 22+41.8°(c=1.25,メタノール) 1760(β‐ラクタムCO)、 1710(ケトンCO)、 1520,1345(ニトロ)。Physicochemical properties of this compound Melting point 90-92 ° C. [α] D 22 + 41.8 ° (c = 1.25, methanol) 1760 (β-lactam CO), 1710 (ketone CO), 1520,1345 (nitro).
【0136】NMR(CDCl3) δ;1.44(3H,dd,J=24.0および6.5Hz、CH
3−CHF−) 2.8−3.2(1H,m,H−3) 3.02(1H,dd,J=18.0および9.0Hz、[0136] NMR (CDCl 3) δ; 1.44 (3H, dd, J = 24.0 and 6.5 Hz, C H
3- CHF-) 2.8-3.2 (1H, m, H-3) 3.02 (1H, dd, J = 18.0 and 9.0Hz,
【0137】[0137]
【化44】 [Chemical 44]
【0138】3.67(1H,dd,J=18.0および4.5
Hz、3.67 (1H, dd, J = 18.0 and 4.5)
Hz,
【0139】[0139]
【化45】 [Chemical formula 45]
【0140】4.02(1H,ddd,J=9.0,4.5および
2.3Hz、H−4)、4.93(1H,dqunit,J=48.0
および6.5Hz,CH3CH−F−)、5.38(2H,s,ベ
ンジル)、6.30(1H,br,NH)、7.56(2H,d,J
=9.0Hz、Ar)、8.28(2H,d,J=9.0Hz、A
r)。4.02 (1H, ddd, J = 9.0, 4.5 and 2.3Hz, H-4), 4.93 (1H, dqunit, J = 48.0)
And 6.5Hz, CH 3 C H -F - ), 5.38 (2H, s, benzyl), 6.30 (1H, br, NH), 7.56 (2H, d, J
= 9.0 Hz, Ar), 8.28 (2 H, d, J = 9.0 Hz, A
r).
【0141】実施例 14(3R,4S)‐4‐アセトキシ‐3‐〔(R)‐1-フルオ
ロエチル〕‐2‐アゼチジノンの製造 Example 14 (3R, 4S) -4-acetoxy-3-[(R) -1-fluor
Preparation of [Rhoethyl] -2-azetidinone
【0142】[0142]
【化46】 [Chemical formula 46]
【0143】(3R,4S)‐4‐アセトキシ‐3‐
〔(R)‐1−フルオロエチル〕‐1‐(p‐メトキシ)フ
エニル‐2‐アゼチジノン 27mg(0.096mmole)を
アセトニトリル1.0mlに溶解後氷冷し、セリツクアン
モニウムナイトレート132mg(0.24mmole)の水溶液
1.0mlをゆっくり滴下した。(3R, 4S) -4-acetoxy-3-
27 mg (0.096 mmole) of ((R) -1-fluoroethyl) -1- (p-methoxy) phenyl-2-azetidinone was dissolved in 1.0 ml of acetonitrile and then cooled with ice, and 132 mg of ceric ammonium nitrate was prepared. 1.0 ml of an aqueous solution of 24 mmole) was slowly added dropwise.
【0144】同温度で30分間反応させた後、反応液を
酢酸エチルに注加し、5%炭酸水素ナトリウム水溶液で
洗浄した。水層は再び酢酸エチルで抽出し、有機層を合
わせ、10%チオ硫酸ナトリウム水溶液、5%炭酸水素
ナトリウム水溶液、飽和食塩水で順次洗浄した。After reacting for 30 minutes at the same temperature, the reaction solution was poured into ethyl acetate and washed with 5% aqueous sodium hydrogen carbonate solution. The aqueous layer was extracted again with ethyl acetate, and the organic layers were combined and washed successively with 10% aqueous sodium thiosulfate solution, 5% aqueous sodium hydrogen carbonate solution and saturated brine.
【0145】無水硫酸ナトリウムによる乾燥後、溶媒を
留去すると表題化合物が15mg得られた(収率89%)。After drying with anhydrous sodium sulfate, the solvent was distilled off to obtain 15 mg of the title compound (yield 89%).
【0146】 1780(β‐ラクタムCO)、 1735(エステルCO)。[0146] 1780 (β-lactam CO), 1735 (ester CO).
【0147】NMR(CDCl3) δ;1.55(3H,dd,J=6.0および24.0Hz、CH
3CHF−)、2.17(3H,s,COCH3)、3.58(1
H,dddd,J3,NH=2.0,J3.4=4.5,J3,CHF=
9.3,J3,F=13.8Hz、H−3)、5.13(1H,dd
q,J=6.0, 9.3および48.0Hz,CH3CHF
−)、6.02(1H,d,J=4.5Hz,H−4)、6.80
(1H,br,NH)。[0147] NMR (CDCl 3) δ; 1.55 (3H, dd, J = 6.0 and 24.0Hz, C H
3 CHF-), 2.17 (3H, s, COCH 3 ), 3.58 (1
H, dddd, J 3, NH = 2.0, J 3. 4 = 4.5, J 3, C H F =
9.3, J 3 , F = 13.8Hz, H-3), 5.13 (1H, dd
q, J = 6.0, 9.3 and 48.0Hz, CH 3 C H F
-), 6.02 (1H, d, J = 4.5Hz, H-4), 6.80
(1H, br, NH).
【0148】実施例 154‐〔(3R,4R)‐3‐((R)‐1‐フルオロエチル)
‐2‐オキソアゼチジン‐4‐イル〕‐2‐ジアゾ‐3
‐オキソ酪酸 p‐ニトロベンジルエステルの合成 Example 15 4-[(3R, 4R) -3-((R) -1-fluoroethyl)
-2-Oxoazetidin-4-yl] -2-diazo-3
Of 2-oxobutyric acid p-nitrobenzyl ester
【0149】[0149]
【化47】 [Chemical 47]
【0150】(3R,4S)‐4‐アセトキシ‐3‐
〔(R)‐フルオロエチル〕‐2‐アゼチジノン 15mg
(0.086mmole)を塩化メチレン1mlに溶解後、氷冷し
ヨウ化亜鉛28mg(0.087mmole)を加えた。この混合
物に0℃でp‐ニトロベンジル2‐ジアゾ‐3‐(トリメ
チルシリル)オキシ‐3‐ブテノエート72mg(0.21m
mole)の塩化メチレン溶液(0.5ml)を10分間かけてゆ
っくり滴下した。(3R, 4S) -4-acetoxy-3-
[(R) -Fluoroethyl] -2-azetidinone 15 mg
(0.086 mmole) was dissolved in 1 ml of methylene chloride, cooled with ice, and 28 mg (0.087 mmole) of zinc iodide was added. To this mixture at 0 ° C p-nitrobenzyl 2-diazo-3- (trimethylsilyl) oxy-3-butenoate 72 mg (0.21 m
A methylene chloride solution (0.5 ml) was slowly added dropwise over 10 minutes.
【0151】反応液は0℃で10分間、ついで室温で2
時間撹拌した。反応液を酢酸エチルで希釈し、5%炭酸
水素ナトリウム水溶液、水、飽和食塩水で順次洗浄し
た。無水硫酸ナトリウムによる乾燥の後に溶媒を留去
し、得られた残渣を分取用TLC(展開系ベンゼン/ア
セトン 3/1)にて精製して、表題化合物13.7mg
(収率42%)を得た。The reaction solution was kept at 0 ° C. for 10 minutes and then at room temperature for 2 minutes.
Stir for hours. The reaction mixture was diluted with ethyl acetate and washed successively with 5% aqueous sodium hydrogen carbonate solution, water and saturated brine. After drying with anhydrous sodium sulfate, the solvent was distilled off, and the obtained residue was purified by preparative TLC (developing system benzene / acetone 3/1) to give 13.7 mg of the title compound.
(Yield 42%) was obtained.
【0152】得られた化合物の理化学的性状は実施例1
3で得られたものと完全に一致した。The physicochemical properties of the obtained compound are shown in Example 1.
It was exactly the same as that obtained in 3.
Claims (1)
ル基を表わし、 R2及びR3は同一もしくは相異なり、各々低級アルキ
ル基を表わす、で示される化合物。1. The formula: In the formula, A represents C H or N, and R 1 is a phenyl which may be substituted with a lower alkoxy group.
It represents Le group, R 2 and R 3 are identical or different, each lower alkyl group a to I Table, in the compound represented.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3356056A JPH0639472B2 (en) | 1991-12-21 | 1991-12-21 | Azole derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3356056A JPH0639472B2 (en) | 1991-12-21 | 1991-12-21 | Azole derivative |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61303915A Division JPS63156788A (en) | 1986-12-22 | 1986-12-22 | Optically active azetidinones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0543575A JPH0543575A (en) | 1993-02-23 |
| JPH0639472B2 true JPH0639472B2 (en) | 1994-05-25 |
Family
ID=18447101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3356056A Expired - Lifetime JPH0639472B2 (en) | 1991-12-21 | 1991-12-21 | Azole derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0639472B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK167878B1 (en) * | 1985-04-19 | 1993-12-27 | Sankyo Co | PIGEOLIC ACID DERIVATIVES |
| KR20090040333A (en) * | 2006-08-15 | 2009-04-23 | 메이지 세이카 가부시키가이샤 | Method for preparing 1-methylcarbapenem intermediate |
| CN101891666B (en) * | 2010-07-20 | 2012-09-26 | 深圳市海滨制药有限公司 | Preparation method of intermediate of beta methylcarbapenem antibiotics |
-
1991
- 1991-12-21 JP JP3356056A patent/JPH0639472B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0543575A (en) | 1993-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4939248A (en) | Optically active azetidinones | |
| FI84716C (en) | Process for the preparation of optically active acyloxyazetidinones | |
| JPH0248556B2 (en) | ||
| US4778883A (en) | 3-(CHFCH3)-azetidinone intermediates | |
| CA2071160A1 (en) | Asymmetric synthesis of taxol side chain | |
| KR20050019764A (en) | Processes for producing epoxytriazole derivative and intermediate therefor | |
| EP0110280B1 (en) | Process for the production of penem compounds | |
| JPH0631255B2 (en) | Penems production method | |
| JPH0543575A (en) | Azole derivative | |
| US4814442A (en) | 6-hydroxyethyl-2-substituted thio-penem-3-carboxylates | |
| HU198067B (en) | Process for producing tautomer thiones | |
| EP0589626B1 (en) | Preparation of beta-methyl carbapenem intermediates | |
| US4952288A (en) | Process for the preparation of 4-acyloxyazetidin-2-one by electrochemical methods | |
| EP0091576B1 (en) | 7-oxo-4-thia-1-azabicyclo(3,2,0)heptane derivatives | |
| EP0192171B1 (en) | Process for chiral synthesis of 1-bêta-methyl-carbapenem intermediates | |
| JPS60185778A (en) | Beta-lactam | |
| KR100335848B1 (en) | Azetidinone derivatives, a process for their preparation and a method for producing 1-β-alkylazetidinone using the same | |
| JP2896949B2 (en) | Method for producing 1- (4-acylphenyl) azoles | |
| JPWO2008020597A1 (en) | Method for producing 1-methylcarbapenem intermediate | |
| KR100283991B1 (en) | Method for preparing bis-triazole derivative | |
| US5134231A (en) | 3(1-hydoxyethyl)azetidinone compounds and their production | |
| EP0404584A2 (en) | Oxidation and reduction method to produce 4-acyloxyazetidin-2-one | |
| JP2620533B2 (en) | New amino acid derivatives | |
| CA1210772A (en) | 7-oxo-4-thia-1-azabicyclo[3,2,0]heptane derivatives | |
| JPH0635432B2 (en) | Novel β-lactam compound |